Central Garden & Pet Balances Margin Gains With Soft Sales

Central Garden & Pet ((CENT)) has held its Q1 earnings call. Read on for the main highlights of the call.

Central Garden & Pet’s latest earnings call struck a cautious but constructive tone. Management highlighted solid margin expansion, strong liquidity and active portfolio reshaping, even as revenue and profits came under pressure from shipment timing, channel transitions and deliberate exits from low-margin lines. The message to investors was one of operational progress offset by near-term sales headwinds.

Revenues and Segment Performance

Central reported net sales of $617 million, with Pet contributing $416 million and Garden $202 million, reflecting a 6% year-over-year decline overall. While headline numbers were soft, key consumable categories like rawhide, wild bird and animal health posted low single-digit growth, underscoring the relative resilience of recurring demand.

Gross Margin Expansion

Despite lower sales, non-GAAP gross margin improved by 100 basis points to 30.8%, with gross profit of $190 million versus $196 million a year ago. Management attributed the expansion to productivity gains and a more favorable mix, indicating that structural efficiency efforts are beginning to offset volume pressure.

Earnings and Profitability Metrics

GAAP diluted EPS came in at $0.11 and non-GAAP diluted EPS at $0.21, matching last year and landing ahead of internal expectations. Non-GAAP adjusted EBITDA was $50 million and non-GAAP net income $13 million, signaling that Central held the earnings line even as the top line contracted.

Operational Transformation and Supply Chain

The company continued modernizing its network by integrating two Garden distribution facilities into modern fulfillment centers and consolidating a fertilizer manufacturing site. These moves are aimed at tighter customer alignment, better service levels and improved cost efficiency, setting up potential operating leverage when volumes recover.

Strategic M&A and Portfolio Optimization

After quarter-end, Central acquired Champion USA, adding an EPA-approved feed-through fly control product for livestock to its portfolio. Management reiterated a disciplined focus on tuck-in deals in margin-accretive consumables, alongside ongoing portfolio rationalization to exit lower-return businesses.

Category Share Gains and Innovation

Central reported share gains in dog treats, flea and tick, pet bird, professional and wild bird, plus fertilizer and packet seeds on the Garden side. Early wins from innovation, including new Nylabone offerings, KT’s Burger Hub and private label momentum, suggest that product development is translating into competitive gains.

Balance Sheet Strength and Liquidity

The company ended the quarter with $721 million in cash and short-term investments, up $103 million from last year, against unchanged total debt of $1.2 billion. Gross leverage sits at 2.9x, below the target range, and net leverage around 1.2x, with no borrowings under the credit facility, giving Central ample financial flexibility.

Capital Allocation Discipline

Management reaffirmed its fiscal 2026 non-GAAP diluted EPS target of $2.70 or better while emphasizing balanced capital allocation. Central repurchased 660,000 shares for $18.5 million in the quarter and still has capacity remaining, while guiding full-year capex to roughly $50–$60 million focused on productivity-enhancing projects.

Top-Line Decline and Garden Weakness

Overall sales fell 6% year over year, with Pet down 3% and Garden down a steeper 12%, as the timing of retailer spring shipments accounted for more than half the company-wide decline. The Garden segment reported a $2 million non-GAAP operating loss versus a $2 million profit previously, and adjusted EBITDA slid to $8 million from $14 million.

Profitability Compression and Durables Drag

Non-GAAP operating income slipped to $24 million from $28 million and adjusted EBITDA eased to $50 million from $55 million, reflecting timing issues and portfolio rationalization. Pet durables, now about 16% of pet sales, declined more than 20%, with roughly two-thirds tied to shipment shifts and the exit of low-margin tank and other SKUs.

Shipment Disruption, Channel Shifts and Cost Structure

Near-term sales were also hurt by a temporary shipment hold with a large pet customer, which was resolved late in the quarter, and by transitioning two third-party Garden distribution lines to direct-to-retail. While non-GAAP SG&A fell 1% in dollar terms to $166 million, it rose as a percentage of sales to 26.8% from 25.5%, underscoring margin sensitivity to lower volume.

Working Capital, Cash Flow and Tariffs

Operating cash flow was a use of $70 million, roughly in line with last year, as inventories increased by $20 million due mainly to shipment timing, and capex stepped up to $11 million from $6 million. Management flagged roughly $20 million in incremental tariff exposure for fiscal 2026, concentrated in Pet, but expects to offset this through pricing, portfolio and supply chain actions.

Guidance and Outlook

Looking ahead, Central reaffirmed its fiscal 2026 non-GAAP EPS outlook of $2.70 or better, implying confidence that margin gains, innovation and efficiency programs can overcome current headwinds. The guidance assumes continued gross margin strength, disciplined SG&A management, steady capex at $50–$60 million and active mitigation of tariff and timing pressures, while excluding any impact from future deals or restructuring.

Central Garden & Pet’s earnings call painted a picture of a company leaning into operational upgrades and higher-margin categories while navigating cyclical and self-inflicted top-line turbulence. For investors, the story hinges on whether seasonal demand, channel normalization and M&A execution can convert today’s margin and liquidity strengths into durable earnings growth by 2026.